Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.
OCRA has invested over $122 million in research initiatives, helped secure $3.8 billion in federal funding for research and education programs, and annually supports and engages more than 95,000 ...
Forbes contributors publish independent expert analyses and insights. Scientists at Cancer Research UK were recently awarded £600,000 to develop the first ovarian cancer vaccine, called OvarianVax.
September is National Ovarian Cancer Awareness Month, a reminder of the importance of knowing the symptoms, talking with your doctor, and taking preventative steps. Ovarian cancer is the deadliest of ...
Human papillomavirus (HPV) remains one of the most prevalent viral infections globally, affecting millions across demographics. While many HPV strains pose minimal risk, certain variants can trigger ...
Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...
News-Medical.Net on MSN
UVA researcher wins $700,000 for promising ovarian cancer research
Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has ...
Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...
This year, an estimated 20,890 women in the U.S. will be diagnosed with ovarian cancer. Even more tragically, an estimated 12 ...
How Does Lynparza Work for Ovarian Cancer? Lynparza is a type of medicine known as poly (ADP-ribose) polymerase (PARP) inhibitor. PARP is a certain protein that helps cancer cells survive and grow. It ...
In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a ...
Elahere is a type of targeted therapy called an antibody-drug conjugate. This antibody-drug conjugate is made up of an antibody that is attached to a cancer medicine. Elahere is used to treat a type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results